SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950116-05-001370
Filing Date
2005-04-15
Accepted
2005-04-15 10:23:04
Documents
1
Period of Report
2005-04-05

Document Format Files

Seq Description Document Type Size
1 3 p405998_ex.html 3  
1 3 p405998_ex.xml 3 1473
  Complete submission text file 0000950116-05-001370.txt   3327
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DSM BIOLOGICS 6000 ROYALMOUNT AVENUE MONTREAL A8 H4P 2T1
Business Address 514-341-9940 XT 222
Amanatides Peter (Reporting) CIK: 0001323564 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25169 | Film No.: 05752371